European Archives - Page 224 of 1347 - European Medical Journal

Exercise May Help Close Survival Gap in Colon Cancer

Research shows that regular physical activity can help close the survival gap for stage III colon cancer, with those who exercise achieving survival rates similar to the general population.

Global Diarrhoeal Deaths Drop, But Burden Persists

This dramatic decline highlights the success of interventions such as oral rehydration therapy, rotavirus vaccination, and improvements in water and sanitation.

UTI Turns Out to Be Infective Endocarditis: An Unusual Presentation

Infective endocarditis (IE) often presents in an unusual and vague manner, especially in its early stages, where symptoms can be…

COMy 2025: Senescence Biomarkers Predict Frailty and Survival in Myeloma

New research, from COMy 2025, has found that specific senescence-associated biomarkers are significantly correlated with frailty and overall survival in newly diagnosed multiple myeloma.

Skin Bacteria Shape Immune Response to UV Light

Interestingly, UVB exposure and topical application of cis-UCA led to changes in the skin’s microbial composition.

EuroPCR 2025: Routine Embolic Protection Not Effective for Stroke Prevention in TAVI

Largest meta-analysis shows no reduction in stroke with routine cerebral embolic protection during TAVI procedures.

Inside the Cancer Vaccine Revolution: Interview with Lennard Lee

I’m a clinical academic, which is quite a rare breed of doctor, because what I’m doing, along with other clinical academics, is being…

PPAR Agonists in PBC

Primary biliary cholangitis (PBC) is characterised by the presence of disease-specific autoantibodies and persistently elevated liver…

22 May 2025

A Novel Therapeutic Target Pathway for Multiple Sclerosis

This interactive infographic gives an overview of a novel target pathway in multiple sclerosis (MS), focusing on the critical role of CD40/CD40L.

Paolo Gallipoli

Hema Now: Episode 17: What Drives Change in Leukaemia Cells?

Paolo Gallipoli, Clinical Reader, Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London joins the podcast to discuss the biology, onset, and treatment of myeloid leukaemias.